China SXT Pharmaceuticals
SXTC
1 hedge funds and large institutions have $769K invested in China SXT Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
67% less capital invested
Capital invested by funds: $2.32M → $769K (-$1.55M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Hudson Bay Capital Management
Stamford,
Connecticut
| $546K | – | – | – |
|
|
HF
2
HRT Financial
New York
| $80K | – | – | – |
|
3
Renaissance Technologies
New York
| $75K | – | – | – |
|
4
UBS Group
Zurich,
Switzerland
| $33K | – | – | – |
|
5
Acadian Asset Management
Boston,
Massachusetts
| $14K | – | – | – |
|
|
ECM
6
ExodusPoint Capital Management
New York
| $11K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| $5K | – | – | – |
|
|
BWA
8
Beam Wealth Advisors
Covington,
Louisiana
| $4K | – | – | – |
|
|
HI
9
Hudock Inc
Williamsport,
Pennsylvania
| $1K | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$7K | – | – |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$10K | – | – |
|
SXTC Hedge Fund Activity: Q3 2020 in Review
1 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in China SXT Pharmaceuticals (SXTC) for Q3 2020, worth a combined $769K — down 67% from $2.32M a quarter earlier.
Fund positioning in SXTC was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Two Sigma Securities, cutting an estimated $10K.
- 1 institutional investor held China SXT Pharmaceuticals (SXTC) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $769K of China SXT Pharmaceuticals stock for Q3 2020, down 67% quarter-over-quarter.
- 0 funds opened new China SXT Pharmaceuticals positions in Q3 2020 and 0 closed out.
- The largest China SXT Pharmaceuticals seller in Q3 2020 was Two Sigma Securities, an estimated $10K sold.
Based on aggregated 13F filings for Q3 2020.